TCIM
TVRD

TIAA CREF Investment Management’s Tvardi Therapeutics TVRD Stock Holding History

TIAA CREF Investment Management’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$1.15M Sell
1,626
-121
-7% -$72.4K ﹤0.01% 2255
2018
Q4 		$817K Sell
1,747
-204
-10% -$132K ﹤0.01% 2356
2018
Q3 		$1.68M Buy
1,951
+314
+19% +$227K ﹤0.01% 2212
2018
Q2 		$1.13M Sell
1,637
-135
-8% -$68.6K ﹤0.01% 2445
2018
Q1 		$790K Hold
1,772
– – ﹤0.01% 2541
2017
Q4 		$781K Sell
1,772
-2,301
-56% -$1.05M ﹤0.01% 2583
2017
Q3 		$2.01M Sell
4,073
-3,849
-49% -$1.93M ﹤0.01% 2164
2017
Q2 		$4.39M Buy
7,922
+316
+4% +$201K ﹤0.01% 1678
2017
Q1 		$5.04M Buy
7,606
+174
+2% +$93K ﹤0.01% 1587
2016
Q4 		$2.48M Buy
7,432
+2,960
+66% +$950K ﹤0.01% 2062
2016
Q3 		$1.34K Buy
4,472
+745
+20% +$161K ﹤0.01% 2381
2016
Q2 		$645K Buy
3,727
+870
+30% +$189K ﹤0.01% 2757
2016
Q1 		$640K Hold
2,857
– – ﹤0.01% 2696
2015
Q4 		$1.73M Buy
2,857
+74
+3% +$40.6K ﹤0.01% 2255
2015
Q3 		$1.43M Buy
2,783
+51
+2% +$34.1K ﹤0.01% 2350
2015
Q2 		$1.2M Buy
2,732
+1,334
+95% +$516K ﹤0.01% 2612
2015
Q1 		$506K Buy
1,398
+263
+23% +$99.5K ﹤0.01% 2916
2014
Q4 		$407K Sell
1,135
-14
-1% -$4.51K ﹤0.01% 3011
2014
Q3 		$347K Sell
1,149
-70
-6% -$28.7K ﹤0.01% 3035
2014
Q2 		$747K Buy
1,219
+556
+84% +$299K ﹤0.01% 2886
2014
Q1 		$444K Buy
+663
New +$392K ﹤0.01% 2973

Other funds holding TVRD

RCP
Rho Capital Partners New York $20.4M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

TIAA CREF Investment Management's TVRD Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Tvardi Therapeutics (TVRD) stake by 6.9% in Q1 2019, selling an estimated $72.4K and leaving 1,626 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #2255.

TIAA CREF Investment Management first reported a position in TVRD in Q1 2014 and has held it in 21 quarters since. The position peaked at $5.04M in Q1 2017. 135 funds tracked by Wall St. Rank hold TVRD as of Q1 2019.

  • TIAA CREF Investment Management held 1,626 shares of Tvardi Therapeutics worth $1.15M as of Q1 2019.
  • TIAA CREF Investment Management sold 121 Tvardi Therapeutics shares in Q1 2019, an estimated $72.4K.
  • Tvardi Therapeutics made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2255 holding.
  • TIAA CREF Investment Management first reported a position in Tvardi Therapeutics in Q1 2014 and has held it in 21 quarters since.
  • TIAA CREF Investment Management's Tvardi Therapeutics position peaked at $5.04M in Q1 2017.
  • 135 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.